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Sato K, Leidal R, Sato F (1987) Morphology and development of an apoeccrine sweat gland in human axillae. Am J Physiol 252: Shehadeh N, Kligman AM (1963a) The effect of topical antibacterial agents on the bacterial flora of the axillae. J Invest Dermatol 40: [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] Shehadeh N, Kligman AM (1963b) The bacteria responsible for apocrine odor, II. J Invest Dermatol 41,1-5 Spielman AI, Zeng X-N, Leyden JJ et al. (1995) Proteinaceous precursors of human axillary odor: isolation of two novel odor binding proteins. Experientia 51:40-7 Spielman AI, Harmony JAK, Stuart WD et al. (1998) Identification and immunohistochemical localization of protein precursors to human axillary odor in apocrine gland secretions. Arch Dermatol 134:813-8 Troccaz M, Strakkenman C, Niclass Y et al. (2004) 3-Methyl-3-sulfanylhexan-1-ol as a major descriptor for the human axilla-sweat odour profile. ) in Denmark at 56°N during the winter. The limitation of these definitions of vitamin D status is discussed in this issue's Editorial, by Reddy and Gilchrest (2010) . The backs and chests of volunteers with skin types I-VI were exposed to three standard erythema doses (SEDs) of UVB for 4 days over 1 week. The UVB source used was very rich in the spectral region that converts 7-dehydrocholesterol to pre-vitamin D in the skin. The sites exposed represent darker skin types, which included V and VI, had lower doses. This study should be confirmed with a larger sample size, and broadened in its remit, but it calls into question much of the dogma about the relationship between pigmentation and vitamin D status, and perhaps even the hypothesis that vitamin D was a major factor in the evolution of skin color (Yuen and Jablonski, 2009 ). However, the data of Bogh et al. are in contrast with those recently published by Armas et al. (2007) in a larger study. Armas et al. exposed 90% of the body surface area three times per week for 4 weeks. The doses given to skin types I/II would be expected to be in the MED range, and doses up to fourfold greater were given to individuals with darker skin types. The estimated increase of 25(OH)D in skin types I/II for a dose of 30 mJ/cm 2 over 4 weeks was comparable to that obtained in 1 week in Bogh and colleagues' study. Higher doses were required for darker skin types. Thus, overall, the outcomes of the two studies, with very different designs, are contradictory. However, it should be noted that the study population of Armas et al. (2007) indicated a relationship between skin color and baseline 25(OH)D, with higher values for fairer skin types. The current study shows that this difference in baseline 24(OH)D levels could have influenced the outcome.
How best to obtain vitamin D
Some three decades ago, some studies compared daily UVR with daily vitamin D supplementation, at different doses, for 3 weeks in vitamin D-deficient/ insufficient people (Stamp et al., 1977) . The UVR details are not comprehensive but would appear to be for whole-body exposure to a source with a peak at 290 nm. The initial "dose" was 1 minute, on dorsal and ventral surfaces, but this was increased by 1 minute each day, except when erythema was present (Stamp, 1975) , indicating that the doses exposed to about 250 SEDs per working year, mostly in the spring and summer (Godar et al., 2001) . This can be increased by 78 SEDs (i.e., about 30%) with a 3-week vacation (i.e., by 3.7 SEDs per day). It is perhaps surprising that even studies in sunny climates have demonstrated suboptimal vitamin D status. This conundrum remains to be investigated and explained.
It is often said that short solar exposures to the face and the back of the hands are adequate to maintain optimal vitamin D status, but this does not seem to have been experimentally verified. Using the technique of Augustsson et al. (1992) , this would be equivalent to ~10% of the body surface and would increase to ~20% if the lower arms are included, which is still less than the ~25% surface area in Bogh and colleagues' study. Whether this is sufficient with lower UVR doses, which are more typical of daily exposure at given latitudes, over a longer period of time, remains to be tested under laboratory and/or field conditions. In this context it should also be noted that an SED of solar UVR will be less effective at vitamin D synthesis than an SED from the very UVB-rich source used in this study. This is because UVA in sunlight makes a much greater contribution to erythema than with the source used by Bogh et al.
Skin color and vitamin D synthesis
Of particular interest is the substudy on the effect of pigmentation (see Table 2 in the article by Bogh et al.) on vitamin D synthesis; people with darker skin tend to have suboptimal vitamin D status. Although the sample size is small (n = 9 pairs matched with similar baseline 25(OH)D), the data indicate that skin type and measured pigmentation have no effect on the synthesis of vitamin D after exposure to the same fixed doses of UVB; this means that from an erythemal (MED) point of view the ~25% body surface area as estimated by the approach of Augustsson et al. (1992) . It should be stressed that an SED is independent of personal UVR sensitivity and is a measure of erythemal efficacy that is independent of source spectrum. A dose of 3 SEDs is equivalent to about 1 minimal erythema dose (MED) in skin types I/II and would be suberythemogenic (approximately 0.5 MED) in skin types III/IV (Harrison and Young, 2002) . The authors show that baseline 25(OH)D is the determinant of the response to UVB exposure. The lower the baseline level, the greater the response, which supports homeostatic control. The regression line in Figure 3 in the article by Bogh et al. indicates that individuals in the insufficient/deficient baseline range had an increase of 20-30 nmol l -1 25(OH)D, a very substantial response, in about 1 week. This essentially brought people who were insufficient into sufficiency and those who were deficient into insufficiency. However, it must be stressed that a relatively large surface area was exposed, and, at least in skin types I/ II, the exposure doses would have been approximately erythemogenic.
The UVR doses used in the study by Bogh and co-workers should be placed into context. The same authors have performed several studies in which UVR exposure was measured over extended periods in different populations in spring/summer in Denmark (56°N) using time-stamped personal electronic dosimeters. In people working indoors without engaging in sun-seeking behavior, the median daily dose was 0.3 SED (range: 0-3.9) on working days and 0.6 SED (range: 0.1-3.5 SED) on their days off (Thieden et al., 2004) . The measurements were taken on subjects' wrists, and it is estimated that the dose to the face is twofold greater. Thus, the doses used in Bogh and colleagues' study were 5-10 times higher than median wrist exposures at the same latitude. Not surprisingly, higher daily exposures have been measured in Queensland, Australia, with, for example, home workers in Brisbane (27.4°S) having weekday shoulder exposure medians of 2.0-8.0 SEDs, depending on the time of year. Outdoor workers at the same latitude showed values of 3.0-10.0 SEDs (Parisi et al., 2000) . It has been estimated that the average American is
Clinical Implications
• Baseline 25(OH)D is a determinant of UVB-induced vitamin D synthesis.
• Vitamin D photosynthesis is independent of skin pigmentation for a fixed UVB dose and similar baseline 25(OH)D level.
• Is adventitious solar exposure of face and hands sufficient to maintain vitamin status?
acterized by the clonal proliferation of skin-homing mature T lymphocytes. 
